Pharmacology & ToxicologyNeuropharmacologyPeer-reviewed
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
Nazzareno Cannella, Veronica Lunerti, Qianwei Shen…·Roberto Ciccocioppo
This study evaluates cebranopadol's efficacy and abuse liability in treating opioid use disorder using rat models, showing reduced self-administration and stress-induced reinstatement compared to heroin.
9 citations